Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-PEG2-propargyl (E3 Ligase Ligand-Linker Conjugates 32) is a chemical compound that has been synthesized as a conjugate of an E3 ligase ligand and a linker. It incorporates the cereblon ligand based on Thalidomide, along with a 2-unit PEG linker. This compound is specifically designed for use in PROTAC technology, which utilizes ligand-induced protein degradation [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 39.00 |
Description | Thalidomide-O-PEG2-propargyl (E3 Ligase Ligand-Linker Conjugates 32) is a chemical compound that has been synthesized as a conjugate of an E3 ligase ligand and a linker. It incorporates the cereblon ligand based on Thalidomide, along with a 2-unit PEG linker. This compound is specifically designed for use in PROTAC technology, which utilizes ligand-induced protein degradation [1]. |
Synonyms | E3 ligase Ligand-Linker Conjugates 32 |
Molecular Weight | 400.38 |
Formula | C20H20N2O7 |
CAS No. | 2098487-52-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-PEG2-propargyl 2098487-52-4 Others Thalidomide-O-PEG-2-propargyl E3 ligase Ligand-Linker Conjugates 32 ThalidomideOPEG2propargyl Thalidomide O PEG2 propargyl inhibitor inhibit